Caribou Biosciences's total assets for Q1 2025 were $273.66M, a decrease of -12.66% from the previous quarter. CRBU total liabilities were $56.43M for the fiscal quarter, a -6.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.